Save
Bookmark
Print
| Sponsor Name | |
| Tumor Site | Small Cell Lung Cancer |
| Disease Stage | Stage IV |
| Clinical Status | Maintenance Therapy |
| Phase | Phase III |
| Intervention / Treatment | Rovalpituzumab Teserine |
| Research Site | Quebec |
| Investigator | Dre Lise Tremblay |
| Telephone Number | 418-656-8711 ext 2639 |
| Study Start Date | January 26, 2017 |
| Study End Date | November 30, 2019 |
| Trial Status | Recruitment Complete |
